SARS-CoV-2 awakens ancient retroviral genes and the expression of proinflammatory HERV-W envelope protein in COVID-19 patients
Benjamin Charvet,
Joanna Brunel,
Justine Pierquin,
Mathieu Iampietro,
Didier Decimo,
Nelly Queruel,
Alexandre Lucas,
María del Mar Encabo-Berzosa,
Izaskun Arenaz,
Tania Perez Marmolejo,
Arturo Ivan Gonzalez,
Armando Castorena Maldonado,
Cyrille Mathieu,
Patrick Küry,
Jose Flores-Rivera,
Fernanda Torres-Ruiz,
Santiago Avila-Rios,
Gonzalo Salgado Montes de Oca,
Jon Schoorlemmer,
Hervé Perron,
Branka Horvat
Affiliations
Benjamin Charvet
GeNeuro Innovation, Lyon, France
Joanna Brunel
GeNeuro Innovation, Lyon, France
Justine Pierquin
GeNeuro Innovation, Lyon, France
Mathieu Iampietro
CIRI, International Center for Infectiology Research, INSERM U1111, CNRS UMR5308, Université de Lyon, Université Claude Bernard Lyon 1, Ecole Normale Supérieure de Lyon, Lyon, France
Didier Decimo
CIRI, International Center for Infectiology Research, INSERM U1111, CNRS UMR5308, Université de Lyon, Université Claude Bernard Lyon 1, Ecole Normale Supérieure de Lyon, Lyon, France
Nelly Queruel
GeNeuro Innovation, Lyon, France
Alexandre Lucas
We-Met platform, I2MC/Inserm/Université Paul Sabatier UMR1297, Toulouse, France
María del Mar Encabo-Berzosa
Biobanco del Sistema de Salud de Aragón, Instituto Aragonés de Ciencias de la Salud (IACS), Zaragoza, Spain
Izaskun Arenaz
Biobanco del Sistema de Salud de Aragón, Instituto Aragonés de Ciencias de la Salud (IACS), Zaragoza, Spain
Tania Perez Marmolejo
Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, México Ciudad, México
Arturo Ivan Gonzalez
Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, México Ciudad, México
Armando Castorena Maldonado
Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, México Ciudad, México
Cyrille Mathieu
CIRI, International Center for Infectiology Research, INSERM U1111, CNRS UMR5308, Université de Lyon, Université Claude Bernard Lyon 1, Ecole Normale Supérieure de Lyon, Lyon, France
Patrick Küry
Department of Neurology, Medical Faculty, Heinrich-Heine-University, Dusseldorf, Germany
Jose Flores-Rivera
Department of Neurology, National Institute of Neurology and Neurosurgery, Mexico City, Mexico
Fernanda Torres-Ruiz
Centro de investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, México Ciudad, México
Santiago Avila-Rios
Centro de investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, México Ciudad, México
Gonzalo Salgado Montes de Oca
Centro de investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, México Ciudad, México
Jon Schoorlemmer
ARAID Fundación; Instituto Aragonés de Ciencias de la Salud (IACS); Grupo B46_20R de la DGA and GIIS-028 del IISA; all Zaragoza, Spain
Hervé Perron
GeNeuro Innovation, Lyon, France; GeNeuro, Plan les Ouates, Geneva, Switzerland; Corresponding author
Branka Horvat
CIRI, International Center for Infectiology Research, INSERM U1111, CNRS UMR5308, Université de Lyon, Université Claude Bernard Lyon 1, Ecole Normale Supérieure de Lyon, Lyon, France; Corresponding author
Summary: Patients with COVID-19 may develop abnormal inflammatory response, followed in some cases by severe disease and long-lasting syndromes. We show here that in vitro exposure to SARS-CoV-2 activates the expression of the human endogenous retrovirus (HERV) HERV-W proinflammatory envelope protein (ENV) in peripheral blood mononuclear cells from a subset of healthy donors, in ACE2 receptor and infection-independent manner. Plasma and/or sera of 221 COVID-19 patients from different cohorts, infected with successive SARS-CoV-2 variants including the Omicron, had detectable HERV-W ENV, which correlated with ENV expression in T lymphocytes and peaked with the disease severity. HERV-W ENV was also found in postmortem tissues of lungs, heart, gastrointestinal tract, brain olfactory bulb, and nasal mucosa from COVID-19 patients. Altogether, these results demonstrate that SARS-CoV-2 could induce HERV-W envelope protein expression and suggest its involvement in the immunopathogenesis of certain COVID-19-associated syndromes and thereby its relevance in the development of personalized treatment of patients.